News
The wealth tech platform says its newly secured patent represents crucial advances in digitizing outdated manual processes.
KIO-104 is for the treatment of a wide range of ocular diseases, including ocular inflammation, uveitis, age-related macular ...
8d
Khaleej Times on MSNUAE, US sign statement to accelerate patent granting proceduresKhaleej Times provides the latest UAE news, Dubai headlines, world events, business updates, dubai gold prices, weather ...
A new fingerprint biometric liveness detection method based on optical coherence tomography (OCT) from India-based Mantra ...
A year’s supply costs over Rs 1 crore, making it nearly impossible for most Indian families to afford. Research suggests it could help them live up to 80 years, compared to the 15–20 years many ...
6d
Emirates News Agency on MSNUAEU researchers awarded US Patent for transformable swarm robots for pipeline maintenanceThe United Arab Emirates University (UAEU) announced that a team of its researchers has been granted a United States Patent ...
Nanovace Technologies Ltd, a subsidiary of PCBL Chemical Ltd, on Monday said it has secured a patent from the US for its ...
The U.S. State Department said on Monday that the Chinese government had blocked a U.S. Patent and Trademark Office employee ...
China bans US employee from leaving country, seizing passport & phone, as tensions rise. US officials cite rising travel ...
This month, during Amazon’s Prime Day—the annual shopping bonanza that offers exclusive discounts to subscribers of the ...
Nanovace Technologies is now setting up a pilot plant, expected to be ready by Q3 FY26, to showcase the industrial-scale viability of its solution.
Celcuity receives US patent for its lead drug candidate, gedatolisib; getting exclusivity up to 2042
Celcuity receives US patent for its lead drug candidate, gedatolisib; getting exclusivity up to 2042: Minneapolis Thursday, July 17, 2025, 16:00 Hrs [IST] Minneapolis-headquartere ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results